LifeStance Health Group, Inc.
corporate_fare Company Profile
LifeStance Health Group, Inc. (NASDAQ:LFST) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 30 items for LFST at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-14, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 11 rated 8 or above. Recent SEC coverage for LFST spans 4, 424B7, 10-Q, 8-K.
Recent high-impact activity:
- LifeStance Chief Legal Officer Sells $40.9M of Stock Under 10b5-1 Plans
- TPG and Summit Price 45M-Share LifeStance Secondary at $13.12, a Discount to Monday's Close
- TPG and Summit Launch 45M-Share Secondary; LifeStance to Buy Back 2M
- LifeStance 10-Q: Q3 Revenue Up 25% to $455.9M, Net Income $22.4M; Material Weaknesses Persist
- LifeStance Lifts Full-Year 2026 Outlook Across Every Metric
Financial Snapshot
Short Interest & Short Volume
4.37 days to coverFINRA reported short interest of 13,664,933 shares in LFST as of the October 30, 2026 settlement, a 0.8% decrease from the prior period — about 4.4 days to cover at its recent average daily volume. On November 13, 2026, 58.3% of LFST volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Moderate riskFiling-implied dilution signals for LFST, detected from its recent SEC filings · based on capital-structure filings through 2026-11-10.
Secondary Offering by Institutional Investors · Company Share Repurchase
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →